Literature DB >> 36032867

External Auditory Canal Cholesteatoma Involving the Vertical Segment of the Facial Nerve: A Rare Case Report.

Raghul Sekar1, Stuti Chowdhary1,2, Arun Alexander1.   

Abstract

External auditory canal cholesteatomas (EACC), are rare, more so when they affect the facial nerve in its vertical mastoid segment. EACC are known to possess bone eroding properties, causing a variety of complications, similar to the better-known attic cholesteatomas. We describe here the novel surgical management of a case of EACC, affecting only the vertical segment of the facial nerve, causing seventh nerve palsy at the time of presentation. A 46 year old male, complaining of right-sided otalgia and otorrhea, presented with grade IV facial palsy and associated mild conductive hearing loss. Clinical examination and radiological investigations suggested the diagnosis of an external auditory canal cholesteatoma. The patient underwent a trans-canal facial nerve decompression along with the cholesteatoma removal. Post-operatively, the patient showed marked clinical improvement with the facial palsy reverting to grade II. EACC involving only the vertical segment of the facial nerve can be approached via the trans-canal route, in contrast to the conventional postauricular approach, with a good clinical outcome. To the best of our knowledge, our case pertains to the only case of EACC with complications, managed by trans-canal facial nerve decompression. © Association of Otolaryngologists of India 2021.

Entities:  

Keywords:  External auditory canal cholesteatoma; Facial nerve; Facial nerve decompression; Facial nerve palsy; Keratosis obturans

Year:  2021        PMID: 36032867      PMCID: PMC9411346          DOI: 10.1007/s12070-020-02325-7

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  10 in total

1.  Neglected keratosis obturans causing facial nerve palsy.

Authors:  F Glynn; I J Keogh; H Burns
Journal:  J Laryngol Otol       Date:  2006-09       Impact factor: 1.469

2.  Surgical Treatment of External Auditory Canal Cholesteatoma - Ten Years of Clinical Experience.

Authors:  Kuen Yao Ho; Tzu Yen Huang; Shih Meng Tsai; Hsun Mo Wang; Chen Yu Chien; Ning Chia Chang
Journal:  J Int Adv Otol       Date:  2017-03-09       Impact factor: 1.017

3.  External ear canal cholesteatoma. Case report.

Authors:  C Hartley; A R Birzgalis; R H Hartley; T J Lyons; W T Farrington
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-11       Impact factor: 1.547

4.  Ear canal cholesteatoma: meta-analysis of clinical characteristics with update on classification, staging and treatment.

Authors:  Patrick Dubach; Georgios Mantokoudis; Marco Caversaccio
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 2.064

5.  Classification of the external auditory canal cholesteatoma.

Authors:  Ramin Naim; Fred Linthicum; Ted Shen; Gregor Bran; Karl Hormann
Journal:  Laryngoscope       Date:  2005-03       Impact factor: 3.325

6.  Ear canal cholesteatoma.

Authors:  J J Holt
Journal:  Laryngoscope       Date:  1992-06       Impact factor: 3.325

7.  External auditory canal cholesteatoma: clinical and imaging spectrum.

Authors:  Marta E Heilbrun; Karen L Salzman; Christine M Glastonbury; H Ric Harnsberger; Richard J Kennedy; Clough Shelton
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

8.  Keratosis obturans and external auditory canal cholesteatoma.

Authors:  M C Piepergerdes; B M Kramer; E E Behnke
Journal:  Laryngoscope       Date:  1980-03       Impact factor: 3.325

9.  Reexamination of Etiology and Surgical Outcome in Patient With Advanced External Auditory Canal Cholesteatoma.

Authors:  Masaya Konishi; Hiroshi Iwai; Koichi Tomoda
Journal:  Otol Neurotol       Date:  2016-07       Impact factor: 2.311

10.  Spontaneous cholesteatoma of the external auditory canal: the utility of CT.

Authors:  S Jerbi Omezzine; M Dakkem; N Ben Hmida; M Saidi; K Ben Rhouma; N Driss; H A Hamza
Journal:  Diagn Interv Imaging       Date:  2013-03-05       Impact factor: 4.026

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.